E-LIB Suche - Ergebnisse für: Tovar Sanchez, Tamara - Sprache EN

Search for persons X

Sorted by: Relevance

Sorted by: Year

1

Risks of metabolic syndrome in the ADVANCE and NAMSAL trial:

Tovar Sanchez, Tamara ; Mpoudi-Etame, Mireille ; Kouanfack, Charles...
Frontiers in Reproductive Health. 5 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

2

Durability of the Efficacy and Safety of Dolutegravir-Based..:

Mpoudi-Etame, Mireille ; Tovar Sanchez, Tamara ; Bousmah, Marwân-al-Qays...
Open Forum Infectious Diseases. 10 (2023) 12 - p. , 2023

Link: https://doi.org/10.1093/..

3

VaccHemInf project: protocol for a prospective cohort study..:

Conrad, Anne ; Boccard, Mathilde ; Valour, Florent...
BMJ Open. 9 (2019) 2 - p. e026093 , 2019

Link: https://doi.org/10.1136/..

4

Effect of anti-Ebola virus monoclonal antibodies on endogen..:

Nkuba-Ndaye, Antoine ; Dilu-Keti, Angele ; Tovar-Sanchez, Tamara...
The Lancet Infectious Diseases. 24 (2024) 3 - p. 266-274 , 2024

Link: https://doi.org/10.1016/..

5

Risks of metabolic syndrome in the ADVANCE and NAMSAL trial:

Tovar Sanchez, Tamara ; Mpoudi-Etame, Mireille ; Kouanfack, Charles...
http://eprints.lse.ac.uk/120539/1/frph_05_1133556.pdf. , 2023

Link: http://eprints.lse.ac.uk..

6

Risks of metabolic syndrome in the ADVANCE and NAMSAL trial:

Tovar Sanchez, Tamara ; Mpoudi-Etame, Mireille ; Kouanfack, Charles...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544962/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Durability of the Efficacy and Safety of Dolutegravir-Based..:

Mpoudi-Etame, Mireille ; Tovar Sanchez, Tamara ; Bousmah, Marwân-al-Qays...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10754645/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Do..:

For The New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group ; Bousmah, Marwân-al-Qays ; Nishimwe, Marie Libérée...
PharmacoEconomics. 39 (2020) 3 - p. 331-343 , 2020

Link: https://doi.org/10.1007/..

9

VaccHemInf project: protocol for a prospective cohort study..:

Conrad, Anne ; Boccard, Mathilde ; Valour, Florent...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398679/. , 2019

Link: http://www.ncbi.nlm.nih...

10

Risks of metabolic syndrome in the ADVANCE and NAMSAL trial:

Tamara Tovar Sanchez ; Mireille Mpoudi-Etame ; Charles Kouanfack...
https://www.frontiersin.org/articles/10.3389/frph.2023.1133556/full. , 2023

Link: https://doi.org/10.3389/..

11

Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Do..:

Bousmah, Marwân-Al-Qays ; Nishimwe, Marie, Libérée ; Tovar-Sanchez, Tamara...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40273-020-00987-3. , 2021

Link: https://hal.umontpellier..

12

Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Do..:

Bousmah, Marwân-Al-Qays ; Nishimwe, Marie, Libérée ; Tovar-Sanchez, Tamara...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40273-020-00987-3. , 2021

Link: https://hal.umontpellier..

13

Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Do..:

Bousmah, Marwân-Al-Qays ; Nishimwe, Marie, Libérée ; Tovar-Sanchez, Tamara...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40273-020-00987-3. , 2021

Link: https://hal.umontpellier..

14

Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Do..:

Bousmah, Marwân-Al-Qays ; Nishimwe, Marie, Libérée ; Tovar-Sanchez, Tamara...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40273-020-00987-3. , 2021

Link: https://hal.umontpellier..

15

Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Do..:

BOUSMAH, Marwân-al-Qays ; Nishimwe, Marie ; Tovar-Sanchez, Tamara...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40273-020-00987-3. , 2021

Link: https://hal.umontpellier..

1-15